Assembly Biosciences, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-3.9M | $-9.1M | $-9.2M | $-10.2M | $-8.8M | $-9.6M | $-11.2M | $-9.1M |
| Depreciation & Amortization | — | $26.0K | — | — | $33.0K | — | — | $32.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $1.1M | — | — | $712.0K | — | — | $739.0K |
| Net Cash from Operating Activities | $-15.5M | $-22.1M | $-15.1M | $-16.8M | $-23.4M | $-15.2M | $-17.1M | $-18.4M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $19.0K | $42.0K | $0 | $0 | $0 | $14.0K | $14.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-5.4M | — | — | $6.6M | — | — | $17.3M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $149.0K | — | — | $1.9M | — | — | $0 |
| Net Change in Cash | — | $-27.3M | — | — | $-14.9M | — | — | $-1.1M |
| Free Cash Flow | $-15.5M | $-22.1M | $-15.2M | $-16.8M | $-23.4M | $-15.2M | $-17.1M | $-18.4M |